Descriptor English: | Valganciclovir | ||||||
Descriptor Spanish: |
Valganciclovir
| ||||||
Descriptor Portuguese: | Valganciclovir | ||||||
Descriptor French: | Valganciclovir | ||||||
Entry term(s): |
Ganciclovir L valyl Ester Ganciclovir L-valyl Ester Valcyt Valcyte Valganciclovir Hydrochloride |
||||||
Tree number(s): |
D03.633.100.759.758.399.454.250.300.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077562 | ||||||
Scope note: | A ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antiviral Agents |
||||||
Registry Number: | GCU97FKN3R | ||||||
CAS Type 1 Name: | L-Valine, 2-((2-amino-3,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester | ||||||
Public MeSH Note: | 2019; VALGANCICLOVIR was indexed under GANCICLOVIR/analogs & derivatives 1999-2018 |
||||||
History Note: | 2019 (1999) |
||||||
DeCS ID: | 57687 | ||||||
Unique ID: | D000077562 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/07/03 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Valganciclovir
- Preferred
Valcyt
- Narrower
Valganciclovir Hydrochloride
- Narrower
Valcyte
- Narrower
Concept UI |
M0334922 |
Scope note | A ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor. |
Preferred term | Valganciclovir |
Entry term(s) |
Ganciclovir L valyl Ester Ganciclovir L-valyl Ester |
Concept UI |
M000640947 |
Preferred term | Valcyt |
Concept UI |
M0398071 |
Preferred term | Valganciclovir Hydrochloride |
Concept UI |
M0398070 |
Preferred term | Valcyte |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey